NCT06876376 Intraoperative Ultrasound in Bowel Deep Endometriosis
| NCT ID | NCT06876376 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Dexeus |
| Condition | Deep Infiltrating Endometriosis With or Without Bowel Involvement |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-01-20 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates the use of intraoperative transvaginal (IOTVUS) and/or endorectal ultrasound (IOERUS) in the surgical treatment of bowel deep infiltrating endometriosis (DIE).
Eligibility Criteria
Inclusion Criteria: * Preoperative sonographic and/or MRI findings suggestive of bowel DIE (uterosacral ligaments, posterior vaginal wall, parametrium, retrocervical area, rectovaginal septum, rectum, and/or sigmoid colon). * Scheduled for surgical treatment (laparoscopy or robot-assisted laparoscopy). * Planned postoperative follow-up for at least 12 months. * Written informed consent provided before surgery. Exclusion Criteria: * Planned surgery for diagnostic purposes only. * Pregnancy at the time of enrollment. * Poor understanding of Spanish or English.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06876376 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Deep Infiltrating Endometriosis With or Without Bowel Involvement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06876376 currently recruiting?
Yes, NCT06876376 is actively recruiting participants. Contact the research team at yanhur@dexeus.com for enrollment information.
Where is the NCT06876376 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT06876376 clinical trial?
NCT06876376 is sponsored by Fundacion Dexeus. The trial plans to enroll 200 participants.